EpiCast Report: Hodgkins Lymphoma - Epidemiology Forecast to 2024

1
EpiCast Report Hodgkins Lymphoma - Epidemiology
Forecast to 2024
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Hodgkins lymphoma (HL), also known as Hodgkins
  disease, is a type of lymphoma, a cancerous
  condition that affects the lymphatic system and
  occurs in both children and adults. HL is a rare
  disease that starts with abnormal growth of the
  white blood cells, called lymphocytes, which
  spreads beyond the lymphatic system and impairs
  the bodys immune system.
• According to the American Cancer Society (ACS),
  HL can start anywhere in the lymphoid tissue of
  body, but quite often starts in the upper part of
  body with main sites in the neck, the chest, or
  under the arms. HL mostly spreads through lymph
  vessels to other lymph nodes, and in advanced
  stages can even invade the bloodstream and spread
  to other organs including the liver, lungs, and
  bone marrow. The most common symptoms of HL
  include enlarged lymph nodes under the skin of
  the neck, under the arm, or in the groin, fever
  (which can come and go over several days or
  weeks) without an infection drenching night
  sweats, and weight loss.
• To forecast the diagnosed incident cases and
  five-year diagnosed prevalent cases of HL in 7MM,
  Epidemiologists obtained data from
  population-based studies that provided
  country-specific data in each of the 7MM. In
  addition, epidemiologists used the staging system
  for HL known as the Cotswold system, which is a
  modification of the older Ann Arbor system, to
  segment the diagnosed incident cases of HL in the
  7MM into stages I, II, III, and IV.
• Read More At http//www.researchbeam.com/epicas
  t-report-hodgkins-lymphoma-epidemiology-forecast-t
  o-2024-market

3


Report Overview
ScopeThe Hodgkins Lymphoma (HL) EpiCast Report
provides an overview of the risk factors and
global trends of HL in the 7MM (US, France,
Germany, Italy, Spain, UK and Japan). It includes
a 10-year epidemiology forecast for the diagnosed
incident cases of HL, segmented by age, sex, and
clinical stage at diagnosis, and types (classical
HL and nodular lymphocyte predominant HL, with
classical HL further segmented into subtypes such
as nodular sclerosis, mixed cellularity,
lymphocyte-rich, and lymphocyte-depleted) in
these markets. In addition, epidemiologists
provide a 10-year epidemiological forecast for
the five-year diagnosed prevalent cases of HL, as
well as the number of HL diagnosed incident cases
refractory to chemoand radiation therapy, the
number of HL diagnosed incident cases who
received autologous stem cell transplantation
(ASCT), and HL diagnosed incident cases
refractory to ASCT from 2014-2024 in these
markets. The HL epidemiology report is written
and developed by Mastersand PhD-level
epidemiologists. The EpiCast Report is in-depth,
high quality, transparent and market-driven,
providing expert analysis of disease trends in
the 7MM.
4


Table of Content
1 Table of Contents 1 Table of Contents 4 1.1
List of Tables 6 1.2 List of Figures 7 2
Introduction 8 2.1 Catalyst 8 2.2 Related Reports
9 3 Epidemiology 11 3.1 Disease Background
11 3.2 Risk Factors and Comorbidities 12 4
Appendix 44 4.1 Bibliography 44 4.2 About the
Authors 47 Enquire At http//www.researchbeam.
com/epicast-report-hodgkins-lymphoma-epidemiology-
forecast-to-2024-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/epicast-report-hodgkin
s-lymphoma-epidemiology-forecast-to-2024-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com